Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Hangzhou economic development zone no. 6 street 5 b03 high-tech incubator building 1, 452

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/L

    Cilengitide is a cyclic peptide containing RGD sequence.
    The peptide alpha v beta 3 integrin ligand based on the body, through the integrated use of cyclization, spatial filtering and methylation scanning and, to the alpha v beta 3 integrin with high affinity and selectivity.
    Test shows that the peptides not only can inhibit the growth of melanoma and gliomas, and cooperate with radiotherapy can improve other tumors, such as the cure rate of the head and neck squamous cell cancer, has good market prospects and potential.
    In peptide synthesis, Cilengitide by solid phase peptide synthesis technology combined with liquid phase peptide synthesis technology.
    Storage: - 20 ℃ under freeze dry, avoid light preservation remark: used only for research, not for human body

Send your message to this supplier
  • From:
  • To:
    Hangzhou Go Top Peptide Biotech Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service